Home/Ai-Biopharma/Dr. Cyril B. Dousson
DC

Dr. Cyril B. Dousson

CEO

Ai-Biopharma

Therapeutic Areas

Ai-Biopharma Pipeline

DrugIndicationPhase
Hepatitis B Virus ProgramHepatitis BPreclinical